Prelude Therapeutics Announces IND Clearance for PRT2527, a High
PRLD: Prelude Therapeutics Incorporated
2021-11-08 09:00:00
Prelude Therapeutics Announces IND Clearance for PRT2527, a Highly Selective CDK9 Inhibitor
2021-11-08 09:00:00
Prelude Therapeutics Announces IND Clearance for PRT2527, a Highly Selective CDK9 Inhibitor
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。